Cargando…
Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?
Von Hippel-Lindau (VHL) disease is an autosomal dominant disorder characterized by the development of multi-organ neoplasms. Among the manifestations of VHL are pancreatic neuroendocrine neoplasms (panNENs). In order to detect these lesions in a timely manner, patients are enrolled in a surveillance...
Autores principales: | Naber, Myrthe R, Ahmad, Saya, Verrijn Stuart, Annemarie A, Giles, Rachel H, Valk, Gerlof D, van Leeuwaarde, Rachel S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763608/ https://www.ncbi.nlm.nih.gov/pubmed/35059546 http://dx.doi.org/10.1210/jendso/bvab191 |
Ejemplares similares
-
Multidisciplinary integrated care pathway for von Hippel–Lindau disease
por: Wolters, Wendy P. G., et al.
Publicado: (2022) -
The incidence of consecutive manifestations in Von Hippel-Lindau disease
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2019) -
Clear cell chondrosarcoma in Von Hippel-Lindau disease
por: Dreijerink, Koen M. A., et al.
Publicado: (2019) -
Non-Interventional Management of Advanced Pancreatic Neuroendocrine Neoplasms in Patients with von Hippel-Lindau Disease
por: Halperin, Reut, et al.
Publicado: (2023) -
Challenges in Von Hippel–Lindau’s disease: PRRT in patients on hemodialysis
por: Ayub, N, et al.
Publicado: (2022)